Ch. Nielsen et al., CHANGES IN BLOOD-LEVELS OF PROTEINASE-INHIBITORS, PREGNANCY ZONE PROTEIN, STEROID CARRIERS AND COMPLEMENT FACTORS INDUCED BY ORAL-CONTRACEPTIVES, European journal of obstetrics, gynecology, and reproductive biology, 51(1), 1993, pp. 63-71
Three low-dose oral contraceptives Trinordiol (R), Gynatrol (R), and M
arvelon (R), containing ethinylestradiol (EE) in combination with trip
hasic levonorgestrel (LNg), monophasic levonorgestrel, and monophasic
desogestrel (DSG), respectively, were given to 65 healthy women, n=21-
22 in each group. Blood levels of antithrombin III (AT III), (alpha(2)
- macroglobulin (alpha(2)M) alpha l-antitrypsin (alpha(1)at), compleme
nt factors (factor B, C3, C4), pregnancy zone protein (PZP), corticost
eroid binding globulin (CBG), sex hormone binding globulin (SHBG) and
albumin were measured before treatment and during the first and third
treatment cycles. AT III levels decreased and alpha(1)at levels increa
sed in all three groups during treatment. Alpha(2)M increased during c
ycle 3 in the Trinordiol and Gynatrol groups. CBG, PZP and SHBG levels
increased in all 3 groups, the CBG and PZP increase being higher in t
he Marvelon group than in the Gynatrol group. Increases in SHBG levels
were found in the order Marvelon > Trinordiol > Gynatrol. Plasma leve
ls of complement factors B, C3 and C4 remained unchanged. It is conclu
ded that the increase in alpha 1at partly compensates for the fall in
AT III, that the rise in PZP presumably enhances fibrinolysis, and tha
t LNg has higher anti-estrogenicity and androgenicity than DSG.